RD-BIOTECH, sees its project to build a production unit "Plasmids GMP" selected by the French State as the winner of the call for projects "AAP Recovery Plan for Industry - Strategic Sectors".
This production unit will complement our current plasma DNA bioproduction capabilities, R&D grade and "High Quality Grade", to meet a very fast growing demand of the new therapies market.

Link to the press release: RD-Biotech winner of the call for projects of France Relance!
Contact us for more information!

RD-Biotech was solicited to participate in this special file "Active ingredients" and present our activities of biomanufacturing of plasmid DNA.
Link to the article: RD-Biotech change de dimension

Contact us for more information!

RD-Biotech provides plasmid DNA production for more than 19 years for a wide range of research, preclinical, clinical and diagnostic applications. Our goal is to provide you with the most affordable, high-quality plasmid DNA manufacturing services that meet your requirements.

Discover our services from Molecular Biology
Contact us for more information!

RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
Signature of license agreements with Institut Pasteur - France and with Winstar Institute - USA: RDBiotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair for ELISA detection of rabies virus glycoprotein G:

- Monoclonal antibody 1112-1: Capture antibody
- Monoclonal antibody D1-25: Detection antibody, biotinylated

Contact us for more information!